Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial.
Plos One
Sutherland, Katherine A KA; Parry, Chris M CM; McCormick, Adele A; Kapaata, Anne A; Lyagoba, Fred F; Kaleebu, Pontiano P; Gilks, Charles F CF; Goodall, Ruth R; Spyer, Moira M; Kityo, Cissy C; Pillay, Deenan D; Gupta, Ravindra K RK; ,